# Coca-Cola Consolidated, Inc.: financial statements, quarterly

COKE · Nasdaq · CIK 317540 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coke.md) · [Financials](/companies/coke/financials.md) · [Filings](/companies/coke/filings.md) · [Insiders](/companies/coke/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/coke/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,712](/filings/0000317540-24-000061.md) | [1,631 d](/filings/0001628280-26-009057.md) | [1,592](/filings/0000317540-25-000053.md) | [1,796](/filings/0000317540-25-000070.md) | [1,766](/filings/0001628280-25-047124.md) | [1,746 d](/filings/0001628280-26-009057.md) | [1,580](/filings/0001628280-26-031302.md) | [1,856](/filings/0001628280-26-053370.md) | [1,888](/filings/0001628280-25-047124.md) | [1,904 d](/filings/0001628280-26-009057.md) | [1,847](/filings/0001628280-26-031302.md) | [2,052](/filings/0001628280-26-053370.md) |
| Cost of revenue | $m | [1,051](/filings/0000317540-24-000061.md) | [989 d](/filings/0001628280-26-009057.md) | [951](/filings/0000317540-25-000053.md) | [1,079](/filings/0000317540-25-000070.md) | [1,068](/filings/0001628280-25-047124.md) | [1,049 d](/filings/0001628280-26-009057.md) | [953](/filings/0001628280-26-031302.md) | [1,113](/filings/0001628280-26-053370.md) | [1,140](/filings/0001628280-25-047124.md) | [1,150 d](/filings/0001628280-26-009057.md) | [1,120](/filings/0001628280-26-031302.md) | [1,274](/filings/0001628280-26-053370.md) |
| Gross profit | $m | [662](/filings/0000317540-24-000061.md) | [641 d](/filings/0001628280-26-009057.md) | [641](/filings/0000317540-25-000053.md) | [717](/filings/0000317540-25-000070.md) | [698](/filings/0001628280-25-047124.md) | [698 d](/filings/0001628280-26-009057.md) | [627](/filings/0001628280-26-031302.md) | [742](/filings/0001628280-26-053370.md) | [749](/filings/0001628280-25-047124.md) | [754 d](/filings/0001628280-26-009057.md) | [727](/filings/0001628280-26-031302.md) | [778](/filings/0001628280-26-053370.md) |
| Selling, general and administrative | $m | [445](/filings/0000317540-24-000061.md) | [463 d](/filings/0001628280-26-009057.md) | [425](/filings/0000317540-25-000053.md) | [458](/filings/0000317540-25-000070.md) | [471](/filings/0001628280-25-047124.md) | [479 d](/filings/0001628280-26-009057.md) | [437](/filings/0001628280-26-031302.md) | [470](/filings/0001628280-26-053370.md) | [502](/filings/0001628280-25-047124.md) | [512 d](/filings/0001628280-26-009057.md) | [490](/filings/0001628280-26-031302.md) | [507](/filings/0001628280-26-053370.md) |
| Operating income | $m | [216](/filings/0000317540-24-000061.md) | [178 d](/filings/0001628280-26-009057.md) | [215](/filings/0000317540-25-000053.md) | [259](/filings/0000317540-25-000070.md) | [227](/filings/0001628280-25-047124.md) | [219 d](/filings/0001628280-26-009057.md) | [190](/filings/0001628280-26-031302.md) | [272](/filings/0001628280-26-053370.md) | [247](/filings/0001628280-25-047124.md) | [242 d](/filings/0001628280-26-009057.md) | [238](/filings/0001628280-26-031302.md) | [271](/filings/0001628280-26-053370.md) |
| Interest expense | $m | [(1.5)](/filings/0000317540-23-000049.md) | [(3.7) d](/filings/0000317540-24-000009.md) | [(2.7)](/filings/0000317540-24-000032.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [28.9](/filings/0000317540-24-000061.md) | [36.7 d](/filings/0001628280-26-009057.md) | [57.1](/filings/0000317540-25-000053.md) | [59.4](/filings/0000317540-25-000070.md) | [39.9](/filings/0001628280-25-047124.md) | [67.1 d](/filings/0001628280-26-009057.md) | [35.9](/filings/0001628280-26-031302.md) | [65.6](/filings/0001628280-26-053370.md) | [49.9](/filings/0001628280-25-047124.md) | [51.0 d](/filings/0001628280-26-009057.md) | [39.7](/filings/0001628280-26-031302.md) | [56.3](/filings/0001628280-26-053370.md) |
| Net income | $m | [92.1](/filings/0000317540-24-000061.md) | [75.8 d](/filings/0001628280-26-009057.md) | [166](/filings/0000317540-25-000053.md) | [173](/filings/0000317540-25-000070.md) | [116](/filings/0001628280-25-047124.md) | [179 d](/filings/0001628280-26-009057.md) | [104](/filings/0001628280-26-031302.md) | [187](/filings/0001628280-26-053370.md) | [142](/filings/0001628280-25-047124.md) | [137 d](/filings/0001628280-26-009057.md) | [112](/filings/0001628280-26-031302.md) | [159](/filings/0001628280-26-053370.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [616](/filings/0000317540-23-000049.md) | [635](/filings/0000317540-25-000025.md) | [401](/filings/0000317540-24-000032.md) | [1,699](/filings/0000317540-24-000046.md) | [1,236](/filings/0000317540-24-000061.md) | [1,136](/filings/0001628280-26-009057.md) | [1,152](/filings/0000317540-25-000053.md) | [1,220](/filings/0000317540-25-000070.md) | [1,532](/filings/0001628280-25-047124.md) | [282](/filings/0001628280-26-053370.md) | [233](/filings/0001628280-26-031302.md) | [172](/filings/0001628280-26-053370.md) |
| Current assets | $m | [1,676](/filings/0000317540-23-000049.md) | [1,705](/filings/0000317540-25-000025.md) | [1,715](/filings/0000317540-24-000032.md) | [3,036](/filings/0000317540-24-000046.md) | [2,571](/filings/0000317540-24-000061.md) | [2,547](/filings/0001628280-26-009057.md) | [2,613](/filings/0000317540-25-000053.md) | [2,731](/filings/0000317540-25-000070.md) | [2,848](/filings/0001628280-25-047124.md) | [1,427](/filings/0001628280-26-053370.md) | [1,500](/filings/0001628280-26-031302.md) | [1,527](/filings/0001628280-26-053370.md) |
| Total assets | $m | [4,141](/filings/0000317540-23-000049.md) | [4,289](/filings/0000317540-25-000025.md) | [4,297](/filings/0000317540-24-000032.md) | [5,656](/filings/0000317540-24-000046.md) | [5,273](/filings/0000317540-24-000061.md) | [5,313](/filings/0001628280-26-009057.md) | [5,404](/filings/0000317540-25-000053.md) | [5,541](/filings/0000317540-25-000070.md) | [5,669](/filings/0001628280-25-047124.md) | [4,303](/filings/0001628280-26-053370.md) | [4,393](/filings/0001628280-26-031302.md) | [4,432](/filings/0001628280-26-053370.md) |
| Current liabilities | $m | [908](/filings/0000317540-23-000049.md) | [1,091](/filings/0000317540-25-000025.md) | [918](/filings/0000317540-24-000032.md) | [1,540](/filings/0000317540-24-000046.md) | [1,041](/filings/0000317540-24-000061.md) | [1,313](/filings/0001628280-26-009057.md) | [1,290](/filings/0000317540-25-000053.md) | [1,339](/filings/0000317540-25-000070.md) | [1,394](/filings/0001628280-25-047124.md) | [1,129](/filings/0001628280-26-053370.md) | [1,215](/filings/0001628280-26-031302.md) | [1,260](/filings/0001628280-26-053370.md) |
| Total liabilities | $m | [2,617](/filings/0000317540-23-000049.md) | [2,853](/filings/0000317540-25-000025.md) | [2,696](/filings/0000317540-24-000032.md) | [4,461](/filings/0000317540-24-000046.md) | [3,988](/filings/0000317540-24-000061.md) | [3,896](/filings/0001628280-26-009057.md) | [3,904](/filings/0000317540-25-000053.md) | [3,911](/filings/0000317540-25-000070.md) | [4,033](/filings/0001628280-25-047124.md) | [5,043](/filings/0001628280-26-053370.md) | [5,036](/filings/0001628280-26-031302.md) | [4,933](/filings/0001628280-26-053370.md) |
| Long-term debt | $m | [599](/filings/0000317540-23-000049.md) | [599](/filings/0000317540-25-000025.md) | [599](/filings/0000317540-24-000032.md) | [1,785](/filings/0000317540-24-000046.md) | [1,786](/filings/0000317540-24-000061.md) | [1,437](/filings/0001628280-26-009057.md) | [1,437](/filings/0000317540-25-000053.md) | [1,438](/filings/0000317540-25-000070.md) | [1,438](/filings/0001628280-25-047124.md) | [2,686](/filings/0001628280-26-053370.md) | [2,537](/filings/0001628280-26-031302.md) | [2,413](/filings/0001628280-26-053370.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0000317540-25-000025.md) | not reported | not reported | not reported | [350](/filings/0001628280-26-009057.md) | [350](/filings/0000317540-25-000053.md) | [350](/filings/0000317540-25-000070.md) | [350](/filings/0001628280-25-047124.md) | [100](/filings/0001628280-26-053370.md) | [100](/filings/0001628280-26-031302.md) | [100](/filings/0001628280-26-053370.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,524](/filings/0000317540-24-000061.md) | [1,436](/filings/0001628280-26-009057.md) | [1,601](/filings/0000317540-25-000070.md) | [1,195](/filings/0001628280-25-047124.md) | [1,285](/filings/0001628280-25-047124.md) | [1,418](/filings/0001628280-26-053370.md) | [1,499](/filings/0001628280-26-053370.md) | [1,630](/filings/0001628280-26-053370.md) | [1,636](/filings/0001628280-25-047124.md) | [(740)](/filings/0001628280-26-053370.md) | [(643)](/filings/0001628280-26-053370.md) | [(500)](/filings/0001628280-26-053370.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [261 d](/filings/0000317540-24-000061.md) | [166 d](/filings/0001628280-26-009057.md) | [194](/filings/0000317540-25-000053.md) | [243 d](/filings/0000317540-25-000070.md) | [271 d](/filings/0001628280-25-047124.md) | [168 d](/filings/0001628280-26-009057.md) | [198](/filings/0001628280-26-031302.md) | [208 d](/filings/0001628280-26-053370.md) | [317 d](/filings/0001628280-25-047124.md) | [209 d](/filings/0001628280-26-009057.md) | [205](/filings/0001628280-26-031302.md) | [215 d](/filings/0001628280-26-053370.md) |
| Capital expenditure | $m | [59.4 d](/filings/0000317540-24-000061.md) | [130 d](/filings/0001628280-26-009057.md) | [77.0](/filings/0000317540-25-000053.md) | [82.4 d](/filings/0000317540-25-000070.md) | [128 d](/filings/0001628280-25-047124.md) | [83.7 d](/filings/0001628280-26-009057.md) | [97.9](/filings/0001628280-26-031302.md) | [59.5 d](/filings/0001628280-26-053370.md) | [52.6 d](/filings/0001628280-25-047124.md) | [102 d](/filings/0001628280-26-009057.md) | [63.1](/filings/0001628280-26-031302.md) | [84.2 d](/filings/0001628280-26-053370.md) |
| Dividends paid | $m | [4.7 d](/filings/0000317540-24-000061.md) | [4.7 d](/filings/0001628280-26-009057.md) | [155](/filings/0000317540-25-000053.md) | [4.7 d](/filings/0000317540-25-000070.md) | [4.4 d](/filings/0001628280-25-047124.md) | [21.9 d](/filings/0001628280-26-009057.md) | [21.8](/filings/0001628280-26-031302.md) | [21.8 d](/filings/0001628280-26-053370.md) | [21.7 d](/filings/0001628280-25-047124.md) | [21.4 d](/filings/0001628280-26-009057.md) | [16.6](/filings/0001628280-26-031302.md) | [16.6 d](/filings/0001628280-26-053370.md) |
| Share repurchases | $m | [0.0 d](/filings/0000317540-24-000061.md) | [0.0 d](/filings/0001628280-26-009057.md) | not reported | not reported | [560 d](/filings/0001628280-25-047124.md) | [51.6 d](/filings/0001628280-26-009057.md) | not reported | not reported | [111 d](/filings/0001628280-25-047124.md) | [2,460 d](/filings/0001628280-26-009057.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2016 (2016-04-03) | Q2 FY2016 (2016-07-03) | Q3 FY2016 (2016-10-02) | Q1 FY2017 (2017-04-02) | Q2 FY2017 (2017-07-02) | Q3 FY2017 (2017-10-01) | Q1 FY2018 (2018-04-01) | Q2 FY2018 (2018-07-01) | Q3 FY2018 (2018-09-30) | Q1 FY2019 (2019-03-31) | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [9,298](/filings/0001564590-17-010528.md) | [9,353](/filings/0001564590-17-016586.md) | [9,353](/filings/0001564590-17-022325.md) | [9,319](/filings/0001564590-18-012526.md) | [9,374](/filings/0001564590-18-020566.md) | [9,374](/filings/0001564590-18-028632.md) | [9,340](/filings/0001564590-19-017342.md) | [9,354](/filings/0001564590-19-029394.md) | [9,405](/filings/0001564590-19-040437.md) | [9,360](/filings/0001564590-19-017342.md) | [9,421](/filings/0001564590-19-029394.md) | [9,413](/filings/0001564590-19-040437.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,141,447 at 2016-03-04, from the cover of the [10-K filed 2016-03-18](/filings/0001564590-16-015048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.